HLB Genex, Inc. (KOSDAQ:187420)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,642.00
-40.00 (-2.38%)
At close: Jul 20, 2026
Market Cap51.25B -47.0%
Revenue (ttm)44.35B +13.7%
Net Income21.41B
EPS580.41
Shares Out 32.64M
PE Ratio2.70
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume135,949
Open1,622.00
Previous Close1,682.00
Day's Range1,503.00 - 1,652.00
52-Week Range1,323.00 - 3,680.00
Beta0.05
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About HLB Genex

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2. The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, o... [Read more]

Industry Industrial Organic Chemicals
Founded 2000
Employees 75
Stock Exchange KOSDAQ
Ticker Symbol 187420
Full Company Profile

Financial Performance

Financial Statements